Iwao Yamaguchi

Author PubWeight™ 53.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Magnetocardiography study on ventricular depolarization-current pattern in patients with brugada syndrome and complete right-bundle branch blocks. Pacing Clin Electrophysiol 2006 1.39
2 Visualization of three-dimensional cardiac electrical excitation using standard heart model and anterior and posterior magnetocardiogram. Int J Cardiovasc Imaging 2006 1.38
3 Aging-induced decrease in the PPAR-alpha level in hearts is improved by exercise training. Am J Physiol Heart Circ Physiol 2002 1.31
4 Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway. J Am Coll Cardiol 2004 1.31
5 Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo. J Pharmacol Sci 2006 1.25
6 Peripartum cardiomyopathy and biventricular thrombi. Circ J 2002 1.25
7 Aerobic exercise training reduces plasma endothelin-1 concentration in older women. J Appl Physiol (1985) 2003 1.14
8 Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway. Circulation 2004 1.04
9 Effect of age on carotid arterial intima-media thickness in childhood. Heart Vessels 2004 1.03
10 Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-knockout mice. Circulation 2002 1.03
11 Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts. Clin Sci (Lond) 2002 1.02
12 Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism. Hypertens Res 2003 0.98
13 The wake of a large vortex is associated with intraventricular filling delay in impaired left ventricles with a pseudonormalized transmitral flow pattern. Echocardiography 2006 0.92
14 Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats. Clin Sci (Lond) 2002 0.91
15 Granulocyte colony-stimulating factor prevents progression of monocrotaline-induced pulmonary arterial hypertension in rats. Circ J 2007 0.90
16 Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up. Heart Rhythm 2010 0.89
17 Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK. Am J Physiol Heart Circ Physiol 2006 0.89
18 Effect of triangle ventricular pacing on haemodynamics and dyssynchrony in patients with advanced heart failure: a comparison study with conventional bi-ventricular pacing therapy. Eur Heart J 2007 0.87
19 Feasibility of targeting catheter ablation to the markedly low-voltage area surrounding infarct scars in patients with post-infarction ventricular tachycardia. Circ J 2008 0.87
20 Involvement of endogenous endothelin-1 in exercise-induced redistribution of tissue blood flow: an endothelin receptor antagonist reduces the redistribution. Circulation 2002 0.85
21 Volume doubling time of lung cancers detected in a chest radiograph mass screening program: Comparison with CT screening. Oncol Lett 2012 0.85
22 The peroxisome proliferator-activated receptor alpha activator fenofibrate inhibits endothelin-1-induced cardiac fibroblast proliferation. J Cardiovasc Pharmacol 2004 0.84
23 Association of sleep-disordered breathing and ventricular arrhythmias in patients without heart failure. Am J Cardiol 2008 0.84
24 Exercise causes a tissue-specific change of NO production in the kidney and lung. J Appl Physiol (1985) 2002 0.84
25 Ventricular fibrillation during anesthesia in association with J waves in the left precordial leads in a child with coarctation of the aorta. J Electrocardiol 2003 0.84
26 Activation of peroxisome proliferator-activated receptor-alpha decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes. J Cardiovasc Pharmacol 2004 0.83
27 Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats. Exp Biol Med (Maywood) 2006 0.82
28 Enhancement of glycolysis in cardiomyocytes elevates endothelin-1 expression through the transcriptional factor hypoxia-inducible factor-1 alpha. Clin Sci (Lond) 2002 0.82
29 Altered expression of endothelin, vascular endothelial growth factor, and its receptor in hepatic tissue in endotoxemic rat. Exp Biol Med (Maywood) 2006 0.82
30 Down-regulated VEGF expression in the diabetic heart is normalized by an endothelin ETA receptor antagonist. Eur J Pharmacol 2006 0.82
31 Exercise training improves cardiac function-related gene levels through thyroid hormone receptor signaling in aged rats. Am J Physiol Heart Circ Physiol 2004 0.82
32 Echolucent carotid plaques as a feature in patients with acute coronary syndrome. Circ J 2006 0.81
33 Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia. Eur J Clin Pharmacol 2006 0.81
34 Alterations in gene expressions encoding preproET-1 and NOS in pulmonary tissue in endotoxemic rats. Exp Biol Med (Maywood) 2006 0.81
35 EPA effect on NOS gene expression and on NO level in endothelin-1-induced hypertrophied cardiomyocytes. Exp Biol Med (Maywood) 2006 0.81
36 Establishment of hypoxia inducible factor-1alpha overexpressing cells that produce endothelin-1. J Cardiovasc Pharmacol 2004 0.79
37 Assessing muscle vasodilation using near-infrared spectroscopy in cardiac patients. Circ J 2005 0.79
38 Endothelin receptor antagonist reverses decreased NO system in the kidney in vivo during exercise. Am J Physiol Endocrinol Metab 2003 0.79
39 Assessment of serum flecainide trough levels in patients with tachyarrhythmia. J Pharm Pharmacol 2005 0.78
40 Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia. Eur J Clin Pharmacol 2007 0.78
41 Repolarization spatial-time current abnormalities in patients with coronary heart disease. Pacing Clin Electrophysiol 2009 0.78
42 Effects of exercise training on expression of endothelin-1 mRNA in the aorta of aged rats. Clin Sci (Lond) 2002 0.78
43 [Magnesium in congestive heart failure]. Clin Calcium 2005 0.78
44 Changes in important apoptosis-related molecules in the endothelin-1-induced hypertrophied cardiomyocytes: effect of the pretreatment with eicosapentaenoic Acid. Exp Biol Med (Maywood) 2006 0.78
45 Simultaneous determination of serum flecainide and its metabolites by using high performance liquid chromatography. J Pharm Biomed Anal 2004 0.78
46 An increase in right atrial magnetic strength is a novel predictor of recurrence of atrial fibrillation after radiofrequency catheter ablation. Circ J 2012 0.78
47 Effects of aging and subsequent exercise training on gene expression of endothelin-1 in rat heart. Clin Sci (Lond) 2002 0.78
48 Peak C-reactive protein concentration correlates with left ventricular thrombus formation diagnosed by contrast echocardiographic left ventricular opacification in patients with a first anterior acute myocardial infarction. Circ J 2006 0.78
49 Integral value of JT interval in magnetocardiography is sensitive to coronary stenosis and improves soon after coronary revascularization. Circ J 2007 0.77
50 Noninvasive recording of his potential using magnetocardiograms. Circ J 2003 0.77
51 Preload-dependent variation of the propagation velocity in patients with congestive heart failure. J Am Soc Echocardiogr 2004 0.77
52 Effects of nicardipine on coronary, vertebral and renal arterial flows in patients with essential hypertension. Hypertens Res 2003 0.77
53 Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting. Circ J 2005 0.77
54 Chronic administration of an endothelin-A receptor antagonist improves exercise capacity in rats with myocardial infarction-induced congestive heart failure. J Cardiovasc Pharmacol 2004 0.77
55 The correlation of irregularities in carotid arterial intima-media thickness with coronary artery disease. Heart Vessels 2002 0.77
56 A combination of oral endothelin-A receptor antagonist and oral prostacyclin analogue is superior to each drug alone in ameliorating pulmonary hypertension in rats. J Am Coll Cardiol 2002 0.76
57 Alterations of gene expressions of preproET-1 and ET receptors in brains of endotoxemic Sprague-Dawley rats. Exp Biol Med (Maywood) 2006 0.76
58 A novel mutation associated with Jervell and Lange-Nielsen syndrome in a Japanese family. Circ J 2008 0.76
59 Endothelin antagonism suppresses plasma and cardiac endothelin-1 levels in SHRSPs at the typical hypertensive stage. Exp Biol Med (Maywood) 2006 0.76
60 Standard template of adult magnetocardiogram. Ann Noninvasive Electrocardiol 2008 0.76
61 Effects of dual endothelin receptor antagonist on antiapoptotic marker Bcl-2 expression in streptozotocin-induced diabetic rats. Exp Biol Med (Maywood) 2006 0.75
62 A porcine model of ischemic heart failure produced by chronic placement of a tube in a coronary artery. Eur J Heart Fail 2003 0.75
63 Continuous intravenous administration of a low dose of epoprostenol greatly decreased serum concentrations of endothelin-1 in primary pulmonary hypertension--a case report. Angiology 2005 0.75
64 [Changes in blood volume in the muscles of the thigh and calf during exercise and recovery and their relationships to exercise tolerance in patients with cardiac disease]. J Cardiol 2002 0.75
65 The endothelin receptor antagonist ameliorates the hypertensive phenotypes of transgenic hypertensive mice with renin-angiotensin genes and discloses roles of organ specific activation of endothelin system in transgenic mice. Life Sci 2004 0.75
66 [Magnetocardiographic diagnosis for myocardial ischemia and arrhythmias]. Rinsho Byori 2006 0.75
67 Enhanced washout of 99mTc-tetrofosmin in hypertrophic cardiomyopathy: quantitative comparisons with regional 123I-BMIPP uptake and wall thickness determined by MRI. Eur J Nucl Med Mol Imaging 2003 0.75
68 YM598, an orally active ET(A) receptor antagonist, ameliorates the progression of cardiopulmonary changes and both-side heart failure in rats with cor pulmonale and myocardial infarction. J Cardiovasc Pharmacol 2004 0.75
69 Effects of linear ablation at the isthmus between the tricuspid annulus and inferior vena cava for atrial flutter on autonomic nervous activity: analysis of heart rate variability. Circ J 2002 0.75
70 Magnetocardiograms in clinical medicine: unique information on cardiac ischemia, arrhythmias, and fetal diagnosis. Intern Med 2005 0.75
71 Addition of spironolactone to an angiotensin-converting enzyme inhibitor decreases lung congestion and edema in Dahl hypertensive rats. Heart Vessels 2006 0.75
72 Effects of anti-vasospastic agents in Japanese patients with dilated cardiomyopathy and coronary vasospasm. Jpn Heart J 2002 0.75
73 Effect of eicosapentaenoic acid on the different endothelin system components in endothelin-1-induced hypertrophied cardiomyocytes. Exp Biol Med (Maywood) 2006 0.75
74 [Combination of oral endothelin-A receptor antagonist and oral prostacyclin analogue is superior to each drug alone in ameliorating pulmonary hypertension in rats]. J Cardiol 2003 0.75
75 Atrial components contributing to pseudo r' deflection in lead V1 in slow/fast atrioventricular nodal reentrant tachycardia: analysis of the atrial activation sequence by basket catheter isochronal mapping. Circ J 2002 0.75
76 Effects of medium-chain triglyceride (MCT) application to SHR on cardiac function, hypertrophy and expression of endothelin-1 mRNA and other genes. J Cardiovasc Pharmacol 2004 0.75
77 Magnesium sulphate infusion suppresses the cardiac release of noradrenaline during a handgrip stress test. Can J Cardiol 2002 0.75
78 Time course alteration of endothelin-1 gene expression in the heart during exercise and recovery from post-exercise periods in rats. J Cardiovasc Pharmacol 2004 0.75
79 Comparison of the effect of the ATP-sensitive potassium channel opener YM934 with that of nitroglycerin on impaired coronary circulation in dogs. Int Heart J 2005 0.75
80 Noninvasive diagnosis of partial atrial standstill using magnetocardiograms. Circ J 2002 0.75
81 Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart. Exp Biol Med (Maywood) 2006 0.75
82 A case of sinus of Valsalva-right ventricle fistula without a typical aneurysm, and a single origin of the coronary arteries. Int Heart J 2005 0.75
83 Assessment of propagation velocity by contrast echocardiography for standardization of color Doppler propagation velocity measurements. J Am Soc Echocardiogr 2004 0.75
84 Electrical space-time abnormalities of ventricular depolarization in patients with Brugada syndrome and patients with complete right-bundle branch blocks studied by magnetocardiography. Pacing Clin Electrophysiol 2006 0.75
85 Endothelin-1-induced cardiomyocyte hypertrophy is partly regulated by transcription factor II-F interacting C-terminal domain phosphatase of RNA polymerase II. Life Sci 2012 0.75
86 A slight increase of fasting plasma glucose after 2 years was associated with electrocardiogram changes suggestive of coronary heart disease in normal subjects. Clin Cardiol 2005 0.75
87 Liquid chromatographic determination of unbound flecainide in therapeutic drug monitoring. J Pharm Biomed Anal 2003 0.75
88 [Magnetocardiograms]. Nihon Rinsho 2003 0.75
89 Amlodipine improves vascular function in patients with moderate to severe hypertension. J Cardiovasc Pharmacol 2003 0.75
90 High performance liquid chromatography for routine monitoring of serum flecainide. J Pharm Biomed Anal 2002 0.75
91 Relationship between mitral annular calcification and severity of carotid atherosclerosis in patients with symptomatic ischemic cerebrovascular disease. J Cardiol 2005 0.75
92 Effects of endothelin-1 eyedrops on the retina in rats. J Cardiovasc Pharmacol 2004 0.75